This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A popular awareness campaign now in its second year that encouraged people to ge...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Jagsonpal Pharmaceuticals and Tyche Industries, both makers of APIs based in Ind...
AstraZeneca is paying $160 million for FibroGen’s Chinese business, giving the U...
Genentech and Novartis have teamed up with FARE to enhance the safety of childre...
AstraZeneca is paying $160 million for Fibrogen’s Chinese business, giving the U...
Ahead of a meeting with President Donald Trump, trade group the Pharmaceutical R...
Bristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperat...
To support the launch of Tryngolza, which is approved to treat adults with famil...
To support the launch of Tryngolza, which is approved to treat adults with famil...
As argenx continues to rise to profitability based on the strength of its indica...
The agency responded to Harmony's bid for an idiopathic hypersomnia nod for exce...
After making a pledge on vaccines to Sen. Bill Cassidy during his confirmation p...
After Novartis and Roche grew their sales last year, the Swiss pharma giants are...
Bristol Myers Squibb has bolstered its case for Opdivo to be used as a pre-opera...
Novartis has committed $7.5 million to an initiative aiming to save 100,000 live...
The FDA has authorized ImmunityBio’s expanded access program to bring alternativ...
Despite AstraZeneca’s revenue growing 18% in 2024, the pay package for CEO Pasca...
Valneva may have won the chikungunya vaccine race with its world-first approval,...
While Exelixis has abandoned a plan to seek an FDA approval for a combination of...
The FDA has given a thumbs up to Sanofi’s Merilog as the first biosimilar substi...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
ICU Medical has voluntarily recalled two lots of potassium chloride intravenous ...
Argenx is urging patients to “Live Vyvidly.” The biotech put the message out in ...